Rimonabant is an anti-obesity medication that assists in weight management for individuals with obesity, particularly those with a body mass index (BMI) of 30 kg/m² or higher. It acts as an appetite suppressant by blocking cannabinoid receptors in the hypothalamus, thereby reducing hunger and promoting weight loss. This medication is particularly relevant for patients with obesity-related health risks, including type 2 diabetes. In summary, Rimonabant aids in weight loss and helps mitigate obesity-related health issues.
Rimonabant functions as a selective antagonist of cannabinoid receptors, leading to decreased appetite and enhanced energy expenditure.
No published brands for this salt yet.